References
- Aronsen K. F., Björkman I., Lindström K., et al. The mechanism of lysine-vasopressin hemostatis in bleeding esophageal varices. Acta chir. Scand. 1979; 145: 231
- Baum S., Nusbaum M. The control of gastrointestinal haemorrhage by selective mesenteric arterial infusion of vasopressin. Radiology 1971; 98: 497
- Bhathal P. S. Presence of modified fibroblasts in cirrhotic livers in man. Pathology 1972; 4: 139
- Chojkier M., Groszmann R. J., Atterbury C. E., et al. A controlled comparison of continuous intra-arterial and intravenous infusions of vasopressin in haemorrhage from esophageal varices. Gastroenterology 1979; 77: 540
- Conn H. O., Ramsby G. R., Storer E. H. Selective intraarterial vasopressin in the treatment of upper gastrointestinal haemorrhage. Gastroenterology 1972; 63: 4, 634
- Davis W. D., Jr., Gorlin R., Reichmann S., et al. Effect of pituitrin in reducing portal pressure in the human being. New Engl. J. Med. 1957; 206: 108
- Duncan D. B. Multiple range tests for correlated and heteroscedastic means. Biometrics 1957; 13: 164
- Erwald R. Vasopressin Tachyphylaxis. Acta chir. Scand. 1976; 142: 30
- Kallio H., Lempinen M. Effect of vasopressin in portal venous pressure. Acta chir. Scand. 1983; 149: 49
- Kehne J. H., Hughes F. A., Gompertz M. L. The use of surgical pituitrin in the control of esophageal varix bleeding. Surgery 1956; 39: 917
- Keiding S., Johansen S., Midtbøll I., et al. Ethanol elimination kinetics in human liver and pig liver in vivo. Amer. J. Physiol. 1979; 237(4:E)316
- Keiding S., Vilstrup H., Hansen L. Importance of flow and haematocrit for metabolic function of perfused rat liver. Scand. J. din. Lab. Invest. 1980; 40: 355
- Merigan T. C., Plotkin G. R., Davidson C. S. Effect of intravenously administered posterior pituitary extract on haemorrhage from bleeding esophageal varices. A controlled evaluation. New Engl.J. Med. 1962; 3: 134
- Millette B., Huet P.-M, Lavoie P., et al. Portal and systemic effects of selective infusion of vasopressin into the superior mesenteric artery in cirrhotic patients. Gastroenterology 1975; 69: 6
- Murray-Lyon I. M., Pugh R. N.H., Nunnerley H. B., et al. Treatment of bleeding oesophageal varices by infusion of vasopressin into the superior mesenteric artery. Gut 1973; 14: 59
- Nusbaum M., Baum S., Kuroda K., et al. Control of portal hypertension by selective mesenteric arterial drug infusion. Arch. Surg. 1968; 97: 1005
- Rabøl A., Juhl E., Schmidt A., et al. The effect of vasopressin® and triglycyl lysine vasopressin (glypressin) on the splanchnic circulation in cirrhotic patients with portal hypertension. Digestion 1979; 14: 285
- Schwartz S. I., Bales H. W., Emerson G. L., et al. The use of intravenous pituitrin in treatment of bleeding esophageal varices. Surgery 1959; 45: 72
- Shaldon S., Sherlock S. The use of vasopressin (‘pitressin’) in the control of bleeding from oesophageal varices. Lancet 1960; 2: 222
- Shaldon S., Dolle W., Guevara L., et al. Effect of pitressin on the splanchnic circulation in man. Circulation 1961; 24: 797
- Sirined K. R., Thomford N. R. Isoproterenol in offsetting adverse effects of vasopressin in cirrhotic patients. Amer. J. Surg. 1975; 129: 130
- Thomford N. R., Sirinek K. R. Intravenous vasopressin in patients with portal hypertension: advantages of continuous infusion. Journal of Surgical Research 1975; 17: 113
- Tygstrup N. Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand. J. din. Lab. Invest. 1966; 18: 118